Chentoufi A, Dhanushkodi N, Srivastava R, Prakash S, Coulon P, Zayou L
Front Immunol. 2022; 13:849515.
PMID: 35547736
PMC: 9082490.
DOI: 10.3389/fimmu.2022.849515.
Mangold C, Szpara M
Viruses. 2019; 11(10).
PMID: 31635156
PMC: 6833100.
DOI: 10.3390/v11100966.
Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K
Kidney Res Clin Pract. 2019; 37(4):323-337.
PMID: 30619688
PMC: 6312768.
DOI: 10.23876/j.krcp.18.0063.
Lopes P, Todorov G, Pham T, Nesburn A, Bahraoui E, BenMohamed L
J Virol. 2018; 92(8).
PMID: 29437976
PMC: 5874417.
DOI: 10.1128/JVI.02156-17.
Royer D, Zheng M, Conrady C, Carr D
Invest Ophthalmol Vis Sci. 2015; 56(6):3763-75.
PMID: 26066745
PMC: 4468912.
DOI: 10.1167/iovs.15-16900.
The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
Kuo T, Wang C, Badakhshan T, Chilukuri S, BenMohamed L
Vaccine. 2014; 32(50):6733-45.
PMID: 25446827
PMC: 4254646.
DOI: 10.1016/j.vaccine.2014.10.002.
An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.
Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V
PLoS One. 2014; 9(7):e100844.
PMID: 25033084
PMC: 4102458.
DOI: 10.1371/journal.pone.0100844.
Towards an effective genital herpes vaccine: past lessons and future prospects.
Halford W
Future Virol. 2013; 2(1):1-6.
PMID: 23843891
PMC: 3704169.
DOI: 10.2217/17460794.2.1.1.
Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.
Halford W, Geltz J, Gershburg E
PLoS One. 2013; 8(6):e65523.
PMID: 23755244
PMC: 3675040.
DOI: 10.1371/journal.pone.0065523.
Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.
Chentoufi A, Dervillez X, Rubbo P, Kuo T, Zhang X, Nagot N
Curr Trends Immunol. 2013; 13:51-68.
PMID: 23355766
PMC: 3552495.
Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.
Chentoufi A, BenMohamed L
Clin Dev Immunol. 2013; 2012:149135.
PMID: 23320014
PMC: 3540975.
DOI: 10.1155/2012/149135.
A vaccine strategy that protects against genital herpes by establishing local memory T cells.
Shin H, Iwasaki A
Nature. 2012; 491(7424):463-7.
PMID: 23075848
PMC: 3499630.
DOI: 10.1038/nature11522.
A neuron-specific role for autophagy in antiviral defense against herpes simplex virus.
Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A
Cell Host Microbe. 2012; 12(3):334-45.
PMID: 22980330
PMC: 3454454.
DOI: 10.1016/j.chom.2012.07.013.
IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice.
Conrady C, Zheng M, Mandal N, van Rooijen N, Carr D
Mucosal Immunol. 2012; 6(1):45-55.
PMID: 22692455
PMC: 3449026.
DOI: 10.1038/mi.2012.46.
CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.
Conrady C, Zheng M, Stone D, Carr D
J Immunol. 2012; 189(1):425-32.
PMID: 22649204
PMC: 3382000.
DOI: 10.4049/jimmunol.1200063.
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.
Chentoufi A, Kritzer E, Yu D, Nesburn A, BenMohamed L
Clin Dev Immunol. 2012; 2012:187585.
PMID: 22548113
PMC: 3324142.
DOI: 10.1155/2012/187585.
Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16.
Conrady C, Zheng M, Fitzgerald K, Liu C, Carr D
Mucosal Immunol. 2012; 5(2):173-83.
PMID: 22236996
PMC: 3288395.
DOI: 10.1038/mi.2011.63.
Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?.
Dasgupta G, BenMohamed L
Vaccine. 2011; 29(35):5824-36.
PMID: 21718746
PMC: 3159167.
DOI: 10.1016/j.vaccine.2011.06.083.
Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro.
de Regge N, Van Opdenbosch N, Nauwynck H, Efstathiou S, Favoreel H
PLoS One. 2010; 5(9).
PMID: 20927329
PMC: 2947521.
DOI: 10.1371/journal.pone.0013076.
17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent.
Miguel R, Sheridan B, Harvey S, Schreiner R, Hendricks R, Cherpes T
J Virol. 2009; 84(1):565-72.
PMID: 19846508
PMC: 2798450.
DOI: 10.1128/JVI.01374-09.
